A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis

Clinical trial NCT05359406 · UNKNOWN

Trial details

NCT number: NCT05359406
Sponsor: LI XIN-XIANG
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Rectal Cancer Distal Metastasis

Start date: 2022-12-01
Primary completion: 2024-06-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.